ReP USP - Resultado da busca

Artigo de periodico
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice (2023)
Silva, Jamile Ramos da ; Rodrigues, Karine Bitencourt ; Pelegrin, Guilherme Formoso ; Sales, Natiely Silva ; Muramatsu, Hiromi ; Silva, Mariângela de Oliveira ; Porchia, Bruna Felício Milazzotto Maldonado ; Moreno, Ana Carolina Ramos ; Aps, Luana Raposo M. M. ; Carvalho, Aléxia Adrianne Venceslau ; Tombácz, István ; Fotoran, Wesley Luzetti ; Karikó, Katalin ; Lin, Paulo J. C.; Tam, Ying K. ; Diniz, Mariana de Oliveira ; Pardi, Norbert ; Ferreira, Luís Carlos de Souza
Fonte: Science Translational Medicine. Unidades: ICB, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, VACINAS VIRAIS, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, PAPILLOMAVIRUS, HPV, INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, PROTEÍNAS RECOMBINANTES, NANOPARTÍCULAS, NUCLEOSÍDEOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jamile Ramos da et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, v. 15, n. 686, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.abn3464. Acesso em: 28 jun. 2024.
APA
Silva, J. R. da, Rodrigues, K. B., Pelegrin, G. F., Sales, N. S., Muramatsu, H., Silva, M. de O., et al. (2023). Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, 15( 686), 1-18. doi:10.1126/scitranslmed.abn3464
NLM
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Vancouver
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Artigo de periodico
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation (2022)
Jesus, Monica Josiane Rodrigues de ; Favaro, Marianna Teixeira de Pinho ; Carvalho, Aléxia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Almeida, Bianca da Silva ; Silva, Mariângela de Oliveira ; Santos, Robert Andreata ; Barbosa, Cecilia Gomes; Brito, Samantha Carvalho Maia; Freitas Junior, Lucio Holanda Gondim de ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Fonte: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: BIOTECNOLOGIA, ICB
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, CORONAVIRUS, COVID-19, LIPOPROTEÍNAS, NANOPARTÍCULAS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, DOENÇAS RESPIRATÓRIAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 28 jun. 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Artigo de periodico
Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil (2022)
Santos, Robert Andreata ; Machado, Rafael Rahal Guaragna ; Alves, Rúbens Prince dos Santos ; Sales, Natiely Silva ; Soares, Camila Pereira ; Rodrigues, Karine Bitencourt ; Andrade, Juliana Bannwart ; Fock, Ricardo Ambrósio ; Margarido, Paulo Francisco Ramos ; Carvalho, Cristiane Rodrigues Guzzo ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Fonte: Frontiers in Cellular and Infection Microbiology. Unidades: HU, ICB, FCF, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, TESTES SOROLÓGICOS, TRIAGEM, SERVIÇOS DE SAÚDE, ESTUDOS RETROSPECTIVOS, ANTICORPOS, ELISA, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 28 jun. 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Artigo de periodico
Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy (2022)
Pagni, Roberta Liberato ; Souza, Patrícia da Cruz; Pegoraro, Rafael; Ribeiro, Bruna Felício Milazzotto Maldonado Porchia ; Silva, Jamile Ramos da ; Aps, Luana Raposo de Melo Moraes; Silva, Mariângela de Oliveira ; Rodrigues, Karine Bitencourt ; Sales, Natiely Silva ; Ferreira, Luís Carlos de Souza ; Moreno, Ana Carolina Ramos
Fonte: Frontiers in Immunology. Unidades: ICB, FM, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, INTERLEUCINA 6, IMUNOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, VACINAS VIRAIS, HPV, CAMUNDONGOS, ENZIMAS OXIRREDUTORAS, ATIVAÇÃO ENZIMÁTICA, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAGNI, Roberta Liberato et al. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, v. 13, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1005937. Acesso em: 28 jun. 2024.
APA
Pagni, R. L., Souza, P. da C., Pegoraro, R., Ribeiro, B. F. M. M. P., Silva, J. R. da, Aps, L. R. de M. M., et al. (2022). Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1005937
NLM
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
Vancouver
Pagni RL, Souza P da C, Pegoraro R, Ribeiro BFMMP, Silva JR da, Aps LR de MM, Silva M de O, Rodrigues KB, Sales NS, Ferreira LC de S, Moreno ACR. Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy [Internet]. Frontiers in Immunology. 2022 ; 13 1-15.[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fimmu.2022.1005937
Artigo de periodico
A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model (2021)
Silva, Jamile Ramos da ; Moreno, Ana Carolina Ramos ; Sales, Natiely Silva ; Silva, Mariângela de Oliveira; Aps, Luana Raposo de Melo Morais ; Ribeiro, Bruna Felicio Milazzotto Maldonado Porchia ; Rodrigues, Karine Bitencourt ; Moreno, Natália Cestari ; Carvalho, Aléxia Adrianne Venceslau ; Menck, Carlos Frederico Martins ; Diniz, Mariana de Oliveira; Ferreira, Luís Carlos de Souza
Fonte: OncoImmunology. Unidades: ICB, BIOTECNOLOGIA, IQ
Assuntos: MICROBIOLOGIA, NEOPLASIAS, HPV, QUIMIOTERAPIA, VACINAS VIRAIS, CÉLULAS CULTIVADAS DE TUMOR, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jamile Ramos da et al. A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model. OncoImmunology, v. 10, n. 1, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1080/2162402X.2021.1949896. Acesso em: 28 jun. 2024.
APA
Silva, J. R. da, Moreno, A. C. R., Sales, N. S., Silva, M. de O., Aps, L. R. de M. M., Ribeiro, B. F. M. M. P., et al. (2021). A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model. OncoImmunology, 10( 1), 1-13. doi:10.1080/2162402X.2021.1949896
NLM
Silva JR da, Moreno ACR, Sales NS, Silva M de O, Aps LR de MM, Ribeiro BFMMP, Rodrigues KB, Moreno NC, Carvalho AAV, Menck CFM, Diniz M de O, Ferreira LC de S. A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model [Internet]. OncoImmunology. 2021 ; 10( 1): 1-13.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1080/2162402X.2021.1949896
Vancouver
Silva JR da, Moreno ACR, Sales NS, Silva M de O, Aps LR de MM, Ribeiro BFMMP, Rodrigues KB, Moreno NC, Carvalho AAV, Menck CFM, Diniz M de O, Ferreira LC de S. A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model [Internet]. OncoImmunology. 2021 ; 10( 1): 1-13.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1080/2162402X.2021.1949896
Artigo de periodico
Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies (2021)
Carvalho, Aléxia Adrianne Venceslau ; Favaro, Marianna Teixeira de Pinho ; Pereira, Lennon Ramos ; Jesus, Mônica Josiane Rodrigues ; Pereira, Samuel Santos ; Santos, Robert Andreata ; Alves, Rúbens Prince dos Santos ; Amarante, Maria Fernanda Castro ; Rodrigues, Karine Bitencourt ; Silva, Jamile Ramos da ; Machado, Rafael Rahal Guaragna ; Cunha, Marielton dos Passos ; Zanotto, Paolo Marinho de Andrade ; Fotoran, Wesley Luzetti ; Wunderlich, Gerhard ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Fonte: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: ICB, BIOTECNOLOGIA
Assuntos: PARASITOLOGIA, MICROBIOLOGIA, VÍRUS CHIKUNGUNYA, PROTEÍNAS RECOMBINANTES, VÍRUS DE RNA, NANOPARTÍCULAS, ANTICORPOS, INFLAMAÇÃO, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Aléxia Adrianne Venceslau et al. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2021.102445. Acesso em: 28 jun. 2024.
APA
Carvalho, A. A. V., Favaro, M. T. de P., Pereira, L. R., Jesus, M. J. R., Pereira, S. S., Santos, R. A., et al. (2021). Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine. doi:10.1016/j.nano.2021.102445
NLM
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Vancouver
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Artigo de periodico
The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age (2021)
Freire, Paula Paccielli ; Marques, Alexandre H. C.; Baiocchi, Gabriela Crispim ; Schimke, Lena Friederike; Fonseca, Dennyson Leeandro Mathias ; Salgado, Ranieri Coelho ; Filgueiras, Igor Salermo ; Napoleão, Sarah Maria da Silva ; Plaça, Desirée Rodrigues ; Akashi, Karen Tiemi; Hirata, Thiago Dominguez Crespo ; Khawanky, Nadia El ; Giil, Lasse Melvaer ; Miranda, Gustavo Cabral de ; Carvalho, Robson Francisco ; Ferreira, Luís Carlos de Souza ; Condino Neto, Antonio ; Nakaya, Helder Takashi Imoto ; Jurisica, Igor ; Ochs, Hans D.; Câmara, Niels Olsen Saraiva ; Calich, Vera Lúcia Garcia ; Marques, Otavio Cabral
Fonte: JCI Insight. Unidades: BIOTECNOLOGIA, ICB, FCF
Assuntos: MICROBIOLOGIA, IMUNOLOGIA, COVID-19, CITOCINAS, INFLAMAÇÃO, NEUTRÓFILOS, GENÉTICA MOLECULAR, DOENÇAS RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, INFECÇÕES RESPIRATÓRIAS, QUIMIOCINAS, SEXO, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREIRE, Paula Paccielli et al. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age. JCI Insight, v. 6, n. 10, p. 1-18, 2021Tradução . . Disponível em: https://doi.org/10.1172/jci.insight.147535. Acesso em: 28 jun. 2024.
APA
Freire, P. P., Marques, A. H. C., Baiocchi, G. C., Schimke, L. F., Fonseca, D. L. M., Salgado, R. C., et al. (2021). The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age. JCI Insight, 6( 10), 1-18. doi:10.1172/jci.insight.147535
NLM
Freire PP, Marques AHC, Baiocchi GC, Schimke LF, Fonseca DLM, Salgado RC, Filgueiras IS, Napoleão SM da S, Plaça DR, Akashi KT, Hirata TDC, Khawanky NE, Giil LM, Miranda GC de, Carvalho RF, Ferreira LC de S, Condino Neto A, Nakaya HTI, Jurisica I, Ochs HD, Câmara NOS, Calich VLG, Marques OC. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age [Internet]. JCI Insight. 2021 ; 6( 10): 1-18.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1172/jci.insight.147535
Vancouver
Freire PP, Marques AHC, Baiocchi GC, Schimke LF, Fonseca DLM, Salgado RC, Filgueiras IS, Napoleão SM da S, Plaça DR, Akashi KT, Hirata TDC, Khawanky NE, Giil LM, Miranda GC de, Carvalho RF, Ferreira LC de S, Condino Neto A, Nakaya HTI, Jurisica I, Ochs HD, Câmara NOS, Calich VLG, Marques OC. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age [Internet]. JCI Insight. 2021 ; 6( 10): 1-18.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1172/jci.insight.147535
Artigo de periodico
Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites (2021)
Silva, Mariângela de Oliveira; Almeida, Bianca da Silva ; Sales, Natiely Silva ; Diniz, Mariana de Oliveira; Aps, Luana Raposo de Melo Morais ; Rodrigues, Karine Bitencourt ; Silva, Jamile Ramos da ; Moreno, Ana Caroline Rippi ; Ribeiro, Bruna Felício Milazzotto Maldonado Porchia ; Sulczewski, Fernando Bandeira ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Fonte: International Journal of Biological Sciences. Unidades: ICB, BIOTECNOLOGIA
Assuntos: MICROBIOLOGUA, PARASITOLOGIA, CÉLULAS DENDRÍTICAS, HPV, IMUNOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, ONCOPROTEÍNAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, v. 17, n. 11, p. 2944-2956, 2021Tradução . . Disponível em: https://doi.org/10.7150/ijbs.57038. Acesso em: 28 jun. 2024.
APA
Silva, M. de O., Almeida, B. da S., Sales, N. S., Diniz, M. de O., Aps, L. R. de M. M., Rodrigues, K. B., et al. (2021). Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, 17( 11), 2944-2956. doi:10.7150/ijbs.57038
NLM
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 jun. 28 ] Available from: https://doi.org/10.7150/ijbs.57038
Vancouver
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 jun. 28 ] Available from: https://doi.org/10.7150/ijbs.57038
Artigo de periodico
Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of response surface methodology (2020)
Kanno, Alex Issamu ; Leite, Luciana Cezar de Cerqueira ; Pereira, Lennon Ramos; Jesus, Mônica Josiane Rodrigues ; Santos, Robert Andreata ; Alves, Rubens Prince dos Santos ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza ; Gonçalves, Viviane Maimoni
Fonte: AMB Express. Unidades: ICB, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA, ZIKA VÍRUS, DENGUE, INFECÇÕES POR ARBOVIRUS, PROTEÍNAS RECOMBINANTES, IMUNOENSAIO, TESTES SOROLÓGICOS, ESCHERICHIA COLI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KANNO, Alex Issamu et al. Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of response surface methodology. AMB Express, v. 10, p. 13 , 2020Tradução . . Disponível em: https://doi.org/10.1186/s13568-019-0926-y. Acesso em: 28 jun. 2024.
APA
Kanno, A. I., Leite, L. C. de C., Pereira, L. R., Jesus, M. J. R., Santos, R. A., Alves, R. P. dos S., et al. (2020). Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of response surface methodology. AMB Express, 10, 13 . doi:10.1186/s13568-019-0926-y
NLM
Kanno AI, Leite LC de C, Pereira LR, Jesus MJR, Santos RA, Alves RP dos S, Durigon EL, Ferreira LC de S, Gonçalves VM. Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of response surface methodology [Internet]. AMB Express. 2020 ; 10 13 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13568-019-0926-y
Vancouver
Kanno AI, Leite LC de C, Pereira LR, Jesus MJR, Santos RA, Alves RP dos S, Durigon EL, Ferreira LC de S, Gonçalves VM. Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of response surface methodology [Internet]. AMB Express. 2020 ; 10 13 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.1186/s13568-019-0926-y
Artigo de periodico
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network (2020)
Araujo, Danielle Bastos ; Machado, Rafael Rahal Guaragna ; Amgarten, Deyvid Emanuel ; Malta, Fernanda de Mello ; Araujo, Gabriel Guarany de ; Monteiro, Cairo Oliveira de ; Candido, Erika Donizette de Oliveira ; Soares, Camila Pereira ; Menezes, Fernando Gatti de; Pires, Ana Carolina Cornachioni; Santana, Rúbia Anita Ferraz ; Viana, Amanda de Oliveira ; Dorlass, Erick Gustavo ; Thomazelli, Luciano Matsumiya ; Ferreira, Luís Carlos de Souza ; Botosso, Viviane Fongaro ; Carvalho, Cristiane Rodrigues Guzzo ; Durigon, Danielle Bruna Leal de Oliveira ; Pinho, João Renato Rebello ; Durigon, Edison Luiz
Fonte: Memórias do Instituto Oswaldo Cruz. Unidades: ICB, FM, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, COVID-19, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, CORONAVIRUS, CORONAVIRIDAE, REAÇÃO EM CADEIA POR POLIMERASE, GENOMAS, SEQUENCIAMENTO GENÉTICO, MICROSCOPIA ELETRÔNICA ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Danielle Bastos et al. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Memórias do Instituto Oswaldo Cruz, v. 115, p. 8 , 2020Tradução . . Disponível em: https://doi.org/10.1590/0074-02760200342. Acesso em: 28 jun. 2024.
APA
Araujo, D. B., Machado, R. R. G., Amgarten, D. E., Malta, F. de M., Araujo, G. G. de, Monteiro, C. O. de, et al. (2020). SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network. Memórias do Instituto Oswaldo Cruz, 115, 8 . doi:10.1590/0074-02760200342
NLM
Araujo DB, Machado RRG, Amgarten DE, Malta F de M, Araujo GG de, Monteiro CO de, Candido ED de O, Soares CP, Menezes FG de, Pires ACC, Santana RAF, Viana A de O, Dorlass EG, Thomazelli LM, Ferreira LC de S, Botosso VF, Carvalho CRG, Durigon DBL de O, Pinho JRR, Durigon EL. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network [Internet]. Memórias do Instituto Oswaldo Cruz. 2020 ; 115 8 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.1590/0074-02760200342
Vancouver
Araujo DB, Machado RRG, Amgarten DE, Malta F de M, Araujo GG de, Monteiro CO de, Candido ED de O, Soares CP, Menezes FG de, Pires ACC, Santana RAF, Viana A de O, Dorlass EG, Thomazelli LM, Ferreira LC de S, Botosso VF, Carvalho CRG, Durigon DBL de O, Pinho JRR, Durigon EL. SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network [Internet]. Memórias do Instituto Oswaldo Cruz. 2020 ; 115 8 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.1590/0074-02760200342
Artigo de periodico
Safety, tumor reduction, and clinical impact of zika virus injection in dogs with advanced-stage brain tumors (2020)
Kaid, Carolini ; Madi, Raquel Azevedo dos Santos; Astray, Renato Mancini ; Goulart, Ernesto ; Caires-Junior, Luiz Carlos ; Mitsugi, Thiago Giove ; Moreno, Ana Carolina Ramos ; Amarante, Maria Fernanda de Castro ; Pereira, Lennon Ramos; Porchia, Bruna Felicio Milazzotto Maldonado; Andrade, Thais Oliveira de ; Landini, Vivian; Sanches, Daniel Soares ; Pires, Carolina Gonçalves ; Tanioka, Rubens Koji Oliveira; Pereira, Marcia C. L; Barbosa, Igor Neves; Massoco, Cristina de Oliveira ; Ferreira, Luís Carlos de Souza ; Okamoto, Oswaldo Keith ; Zatz, Mayana
Fonte: Molecular Therapy. Unidades: BIOTECNOLOGIA, FMVZ, ICB, IB
Assuntos: CÃES, ZIKA VÍRUS, NEOPLASIAS EM ANIMAL, NEOPLASIAS DO SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAID, Carolini et al. Safety, tumor reduction, and clinical impact of zika virus injection in dogs with advanced-stage brain tumors. Molecular Therapy, v. 28, n. 5, p. 1276-1286, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ymthe.2020.03.004. Acesso em: 28 jun. 2024.
APA
Kaid, C., Madi, R. A. dos S., Astray, R. M., Goulart, E., Caires-Junior, L. C., Mitsugi, T. G., et al. (2020). Safety, tumor reduction, and clinical impact of zika virus injection in dogs with advanced-stage brain tumors. Molecular Therapy, 28( 5), 1276-1286. doi:10.1016/j.ymthe.2020.03.004
NLM
Kaid C, Madi RA dos S, Astray RM, Goulart E, Caires-Junior LC, Mitsugi TG, Moreno ACR, Amarante MF de C, Pereira LR, Porchia BFMM, Andrade TO de, Landini V, Sanches DS, Pires CG, Tanioka RKO, Pereira MCL, Barbosa IN, Massoco C de O, Ferreira LC de S, Okamoto OK, Zatz M. Safety, tumor reduction, and clinical impact of zika virus injection in dogs with advanced-stage brain tumors [Internet]. Molecular Therapy. 2020 ; 28( 5): 1276-1286.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.ymthe.2020.03.004
Vancouver
Kaid C, Madi RA dos S, Astray RM, Goulart E, Caires-Junior LC, Mitsugi TG, Moreno ACR, Amarante MF de C, Pereira LR, Porchia BFMM, Andrade TO de, Landini V, Sanches DS, Pires CG, Tanioka RKO, Pereira MCL, Barbosa IN, Massoco C de O, Ferreira LC de S, Okamoto OK, Zatz M. Safety, tumor reduction, and clinical impact of zika virus injection in dogs with advanced-stage brain tumors [Internet]. Molecular Therapy. 2020 ; 28( 5): 1276-1286.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.ymthe.2020.03.004
Artigo de periodico
Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR (2020)
Dorlass, Erick Gustavo ; Oliveira, Cairo Monteiro de ; Viana, Amanda de Oliveira ; Soares, Camila Pereira ; Machado, Rafael Rahal Guaragna ; Thomazelli, Luciano Matsumiya ; Araújo, Danielle Bastos ; Oliveira, Fabyano Bruno Leal de; Candido, Erika Donizette de Oliveira ; Lopes, Bruna Larotonda Telezynski ; Valério, Camila Araujo ; Chalup, Vanessa Nascimento ; Mello, Ralyria ; Almeida, Flávia Jacqueline ; Aguiar, Andressa Simões ; Barrientos, Anna Carlotta Mott ; Sucupira, Carolina ; Paulis, Milena De ; Sáfadi, Marco Aurélio Palazzi ; Silva, Daniella Gregoria Bomfim Prado da ; Fock, Ricardo Ambrósio ; Ferreira, Luís Carlos de Souza ; Durigon, Edison Luiz ; Durigon, Danielle Bruna Leal de Oliveira
Fonte: Brazilian Journal of Microbiology. Unidades: ICB, HU, FCF, BIOTECNOLOGIA
Assuntos: CORONAVIRUS, MICROBIOLOGIA, REAÇÃO EM CADEIA POR POLIMERASE, COVID-19, VÍRUS DE RNA, INFECÇÕES POR VÍRUS DE RNA, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DORLASS, Erick Gustavo et al. Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR. Brazilian Journal of Microbiology, v. 51, p. 1117–1123, 2020Tradução . . Disponível em: https://doi.org/10.1007/s42770-020-00347-5. Acesso em: 28 jun. 2024.
APA
Dorlass, E. G., Oliveira, C. M. de, Viana, A. de O., Soares, C. P., Machado, R. R. G., Thomazelli, L. M., et al. (2020). Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR. Brazilian Journal of Microbiology, 51, 1117–1123. doi:10.1007/s42770-020-00347-5
NLM
Dorlass EG, Oliveira CM de, Viana A de O, Soares CP, Machado RRG, Thomazelli LM, Araújo DB, Oliveira FBL de, Candido ED de O, Lopes BLT, Valério CA, Chalup VN, Mello R, Almeida FJ, Aguiar AS, Barrientos ACM, Sucupira C, Paulis MD, Sáfadi MAP, Silva DGBP da, Fock RA, Ferreira LC de S, Durigon EL, Durigon DBL de O. Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 1117–1123.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1007/s42770-020-00347-5
Vancouver
Dorlass EG, Oliveira CM de, Viana A de O, Soares CP, Machado RRG, Thomazelli LM, Araújo DB, Oliveira FBL de, Candido ED de O, Lopes BLT, Valério CA, Chalup VN, Mello R, Almeida FJ, Aguiar AS, Barrientos ACM, Sucupira C, Paulis MD, Sáfadi MAP, Silva DGBP da, Fock RA, Ferreira LC de S, Durigon EL, Durigon DBL de O. Lower cost alternatives for molecular diagnosis of COVID-19: conventional RT-PCR and SYBR Green-based RT-qPCR [Internet]. Brazilian Journal of Microbiology. 2020 ; 51 1117–1123.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1007/s42770-020-00347-5
Artigo de periodico
Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization (2020)
Santos, Nayara Fernanda Barros dos; Silva, Lukas Raposo da; Costa, Fagner James Martins Dantas; Mattos, Daniely Maranhão de; Carvalho, Enéas de ; Ferreira, Luís Carlos de Souza ; Ferreira, Rita de Cássia Café
Fonte: Vaccine. Unidades: ICB, BIOTECNOLOGIA
Assuntos: MICROBIOLOGIA, IMUNIZAÇÃO, PROTEÍNAS RECOMBINANTES, IMUNIDADE, CAMUNDONGOS, STREPTOCOCCUS, ANTIBIÓTICOS, VACINAS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Nayara Fernanda Barros dos et al. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization. Vaccine, v. 38, n. 33, p. 5286-5296, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2020.05.076. Acesso em: 28 jun. 2024.
APA
Santos, N. F. B. dos, Silva, L. R. da, Costa, F. J. M. D., Mattos, D. M. de, Carvalho, E. de, Ferreira, L. C. de S., & Ferreira, R. de C. C. (2020). Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization. Vaccine, 38( 33), 5286-5296. doi:10.1016/j.vaccine.2020.05.076
NLM
Santos NFB dos, Silva LR da, Costa FJMD, Mattos DM de, Carvalho E de, Ferreira LC de S, Ferreira R de CC. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization [Internet]. Vaccine. 2020 ; 38( 33): 5286-5296.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.vaccine.2020.05.076
Vancouver
Santos NFB dos, Silva LR da, Costa FJMD, Mattos DM de, Carvalho E de, Ferreira LC de S, Ferreira R de CC. Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization [Internet]. Vaccine. 2020 ; 38( 33): 5286-5296.[citado 2024 jun. 28 ] Available from: https://doi.org/10.1016/j.vaccine.2020.05.076
Artigo de periodico
The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors (2018)
Moreno, Ana Caroline Rippi; Ribeiro, Bruna Felicio Milazzotto Maldonado Porchia; Pagni, Roberta Liberato; Sousa, Patricia da Cruz; Pegoraro, Rafael; Rodrigues, Karine Bittencourt; Barros, Tácita Borges; Aps, Luana R. de Melo Moraes; Araujo, Eliseu Frank de; Calich, Vera Lucia Garcia; Ferreira, Luís Carlos de Souza
Fonte: Frontiers in Immunology. Unidades: ICB, BIOTECNOLOGIA, FCF
Assuntos: MELATONINA, IMUNOLOGIA CELULAR, VACINAS VIRAIS, IMUNOTERAPIA, HPV, NEOPLASIAS CUTÂNEAS, HPV, ADJUVANTES IMUNOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Ana Caroline Rippi et al. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors. Frontiers in Immunology, v. 9, p. 14 , 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.01914. Acesso em: 28 jun. 2024.
APA
Moreno, A. C. R., Ribeiro, B. F. M. M. P., Pagni, R. L., Sousa, P. da C., Pegoraro, R., Rodrigues, K. B., et al. (2018). The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors. Frontiers in Immunology, 9, 14 . doi:10.3389/fimmu.2018.01914
NLM
Moreno ACR, Ribeiro BFMMP, Pagni RL, Sousa P da C, Pegoraro R, Rodrigues KB, Barros TB, Aps LR de MM, Araujo EF de, Calich VLG, Ferreira LC de S. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors [Internet]. Frontiers in Immunology. 2018 ; 9 14 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fimmu.2018.01914
Vancouver
Moreno ACR, Ribeiro BFMMP, Pagni RL, Sousa P da C, Pegoraro R, Rodrigues KB, Barros TB, Aps LR de MM, Araujo EF de, Calich VLG, Ferreira LC de S. The combined use of melatonin and an indoleamine 2,3-dioxygenase-1 inhibitor enhances vaccine-induced protective cellular immunity to HPV16-associated tumors [Internet]. Frontiers in Immunology. 2018 ; 9 14 .[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fimmu.2018.01914

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos